Andere talen Xenetic Biosciences, Inc.

Aandelen

XBIO

US9840156023

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,27 ^USD	+9,49%		+4,40%	+23,76%

21/03	Xenetic Biosciences, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
18/03	CLS Therapeutics onthult zijn mening over Xenetic Biosciences	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results	25/03
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K	22/03
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CLS Therapeutics Discloses its Views on Xenetic Biosciences	18/03
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of Its DNase-Based Oncology Platform	17/01
Xenetic Biosciences: Q3 Earnings Snapshot	10/11
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference	12-10-23
Xenetic Biosciences: Q2 Earnings Snapshot	11-08-23
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
North American Morning Briefing : Debt-Ceiling -2-	17-05-23
Xenetic Biosciences to Implement 1-for-10 Reverse Split	12-05-23
Xenetic Biosciences: Q1 Earnings Snapshot	11-05-23
XENETIC BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11-05-23
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11-05-23
Xenetic Biosciences, The Scripps Research Institute Enter Into Research Collaboration	11-04-23
Xenetic Biosciences : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K	23-03-23
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-23
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-22
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	09-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Xenetic Biosciences, Inc.

Aandelen

XBIO

US9840156023

Andere talen

Filters